PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Pharma Market Research Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

/RC/ Healthcare and Pharma Experts to Tackle 2013’s Most Critical Issues - Healthcare and pharmaceutical industry leaders are looking toward 2013 as a time of big decisions, many of which will be influenced by the Pharma Market Research Conference - PharmaMarketResearchConference.com
/RC/ Healthcare and Pharma Experts to Tackle 2013’s Most Critical Issues

 

NewswireToday - /newswire/ - East Brunswick, NJ, United States, 2012/07/11 - Healthcare and pharmaceutical industry leaders are looking toward 2013 as a time of big decisions, many of which will be influenced by the Pharma Market Research Conference - PharmaMarketResearchConference.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

For anyone affected by health insurance or prescription drugs, buzz is building for the first major event in 2013 that everyone will be discussing. Healthcare, pharmaceutical, biotechnology, medical devices, and other life sciences professionals all know there is only one place to be on February 5-6, 2013- the Pharma Market Research Conference at the Hilton East Brunswick in East Brunswick, New Jersey.

“I thought the Pharma Market Research conference was a great venue to tap into key trends occurring in our industry, learn of cutting-edge market research approaches and technologies to tackle business challenges, and engage with colleagues in our field. The program and exhibits were excellent,” said a participant from GlaxoSmithKline.

Industry experts will share their knowledge, including thought leaders from Allergan, Alexion, Auxilium, Bayer, Bristol-Myer Squibb, GE Healthcare, Johnson & Johnson, Merck, Novartis, Pfizer, Shionogi, Shire, Takeda, Upsher-Smith, and many more!

The Pharma Market Research Conference is buoyed by an impressive advisory board of clear industry leaders. Advisory board members are helping shape the program agenda to make sure the most critical issues are all covered. Stay tuned for details to be released about the exciting program!

“Great conference! Compelling insights offered by a broad cross-section of Pharma Market Research experts!,” said a participant from AstraZeneca.

“The Pharma Market Research Conference is a terrific opportunity to stay up to date on the latest tools and techniques of our craft. The multi-track system offers flexibility to attend seminars that best meet your needs. And re-connecting with colleagues I haven’t seen in a while was another positive benefit,” said a participant from Johnson & Johnson.

The Pharma Market Research Conference is your EXCLUSIVE ENTRY into the world of pharmaceutical market research. Nowhere else will you find the industry's best and brightest all under one roof! More than 300 people came in 2012. The exhibit space sold out! Feedback has been overwhelmingly positive as 2013 is on track for even more success for all participants.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Pharma Market Research Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


/RC/ Healthcare and Pharma Experts to Tackle 2013’s Most Critical Issues

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: PharmaMarketResearchConference.com 
212-228-7974 info[.]pharmamarketresearchconference.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Pharma Market Research Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Pharma Market Research Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)